Kansas recalls
4349 federal recalls on file affecting Kansas - 364 Kansas-specific plus 3985 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-07-29FDA-DrugFresenius KabiClass IINationwideFresenius Kabi lidocaine injection recalled for hair contamination
Presence of Particulate Matter: Hair was found in products
- 2026-07-29FDA-DrugFresenius KabiClass IINationwideFresenius Kabi glycopyrrolate injection recalled for particulate contamination
Presence of Particulate Matter: Hair was found in product
- 2026-07-29FDA-DrugRising PharmaClass IINationwideRising Cyproheptadine Hydrochloride Syrup recalled for precipitate
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility issue
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concern
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops Digi Eye recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops Max Strength recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops Max Strength recalled for sterility risk
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugAscend LaboratoriesClass IINationwideAscend amlodipine-olmesartan tablets recalled for low drug content
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine 125 mcg recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for low potency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine recalled for reduced potency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine 112 mcg recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine Sodium Tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for reduced potency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugPrecision DoseNot Yet ClassifiedNationwidePrecision Dose glycopyrrolate solution recalled for impurity
Due to an out-of-specification result for an unidentified impurity detected during routine stability testing.
- 2026-07-24FDA-PRSunny PharmtechNationwideSunny Pharmtech Cyclophosphamide recalled for steel particles
July 24, 2026 - Taoyuan City, Taiwan - Sunny Pharmtech, Inc is voluntarily recalling three lots of Cyclophosphamide for Injection, USP, 1g/vial and 2g/vial, to the User Level due to the presence of particulate matter identified as steel. To date, no adverse events or injuries associated with this pa
- 2026-07-24FDA-PRBaxterNationwideBaxter Cefazolin Dextrose Injection recalled for particulate contamination
July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.<br> Risk Statement: The use of the defective product has a
- 2026-07-24FDA-PRAmerican RegentNationwideAmerican Regent Papaverine Injection recalled for glass particles
July 24, 2026 – Shirley, NY, American Regent, Inc. is conducting a nationwide voluntary recall of a single lot of Papaverine Hydrochloride Injection, USP, 60 mg/2 mL single dose vial to the consumer level. The product is being recalled due to the presence of particulate matter identified as glass an
- 2026-07-23CPSCPeony DesignNationwidePeony Design baby bibs and stroller bags recalled for choking hazard
The snap can detach from the recalled bibs and stroller bags, posing a risk of serious injury or death from a choking hazard to young children.
- 2026-07-23CPSCYouRfocusNationwideCuddleCubs Creations teething toys recalled for choking risk
The recalled teething toy sets contain a pull string teething toy that violates the mandatory standard for toys because the silicone strings are smaller and longer than permitted. The strings can reach the back of a child's throat and become lodged, posing a risk of respiratory distress and a deadly choking hazard.
Get notified about new Kansas recalls
Free weekly digest. Add Kansas to your profile to filter alerts to your state.
Get the Sunday Brief